Iovance Biotherapeutics

Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. The company is committed to continuous innovation in cell therapy, including gene-edited cell therapy, which may be a promising option for patients with cancer.